Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Obstetrics/Gynecology General

RSS  

Articles

  • Educational Sessions for Women with Opioid Use Disorder Improve Engagement

    A Maine family planning clinic launched a program to reach women who experience barriers to reproductive healthcare, counseling, and testing for sexually transmitted infections. The program focused on outreach, sending an educator to various locations and providing an educational session for women who are especially vulnerable, including those who use opioids.

  • Study: Risk Assessment for Contraceptives Is Influenced by Cultural Biases

    Cultural assumptions create unbalanced risk assessment when the medical community weighs the risks and benefits of common contraceptive methods, the authors of a recent study concluded. Researchers studied contraception risks and assessed how these risks were prioritized in reproductive health providers’ understanding of contraceptives and their potential side effects.

  • Study: Contraception Program for Incarcerated Women Can Prevent Pregnancies

    An estimated 5% of women in jails are pregnant, and human rights groups and researchers have collected evidence that these women often receive poor care and are neglected. One solution is to provide contraceptive care to incarcerated women who would like to avoid pregnancy.

  • Contraceptive Use Is Less Consistent for Young Women Experiencing Hardships

    Researchers studied more than 1,000 women, ages 18 and 19 years, over several years, asking them weekly questions about their contraceptive use, sex, and pregnancy. They found that women who experience material hardship use contraceptives less consistently.

  • Researchers Study Immigrant Latinas’ Experience with Reproductive Healthcare

    Latina-identified immigrants experience multiple barriers to healthcare, including contraception and reproductive care. This can result in lack of access to affordable preventive screenings, such as Pap smears, mammograms, and tests for sexually transmitted infections, according to the authors of a recent study.

  • Supreme Court Decision Reinforces Barrier to Medication Abortion

    A recent decision by the U.S. Supreme Court could make it more difficult for women to access medication abortions. In an unsigned brief order on Jan. 12, the Supreme Court said a district court should not have compelled the Food and Drug Administration to lift a requirement that mifepristone, the abortion pill, has to be picked up in person.

  • New Year, New President Affect Abortion, Title X Changes

    Family planning providers anticipate positive changes to the Title X program as President Biden announced his administration would roll back the Trump rules that forced hundreds of family planning clinics out of the program.

  • Study: IUD Counseling Can Appear Coercive

    The results of a recent study revealed that providers might think they are promoting their young patients’ decision-making, but their focus on intrauterine devices and other long-acting reversible contraceptives can come across as coercive.

  • Pregnancy Risk Increases When Young Women Travel

    Although most international trips, including students’ study abroad programs, were put on hold in 2020, these might resume this year after the COVID-19 vaccine reaches student populations. Reproductive health providers can help young women prepare for the contraceptive needs and uncertainties of travel. A new study revealed that young female travelers overwhelmingly say they will be abstinent during their travels, but their actual experience is the opposite.

  • New Contraceptive Patch Is a Weekly Option

    Twirla, a new low-dose contraceptive patch, is effective at preventing pregnancy among American women, according to researchers. Phase III clinical trial results were favorable for efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system. The new patch uses a progestin and contains less estrogen than prior patches.